Mary C, Goudard M, Blancard A, Quilici M, Regli P
Laboratoire de Parasitologie Mycologie, Faculté de Médecine, Marseille.
Ann Biol Clin (Paris). 1989;47(9):546-9.
Antifungal agents associations are widely used in therapy of deep mycotic diseases, particularly amphotericin B-5-fluorocytosine association. Synergistic effect has also been described between 5-fluorocytosine and imidazole derivates. The authors have tested here eventual synergy between 5-fluorocytosine and imidazole derivatives (miconazole, ketoconazole, fluconazole, itraconazole) against 57 years isolates resistant to 5-fluorocytosine by a semi-automated methods in liquid medium (Yeast Nitrogen Base and Brain Heart Infusion). The synergistic effect between 5-fluorocytosine and antifungal imidazoles varies widely with the drug tested. It's more frequent with ketoconazole. Itraconazole and fluconazole present very little synergistic effects in vitro.
抗真菌药物联合用药广泛应用于深部真菌病的治疗,尤其是两性霉素B-5-氟胞嘧啶联合用药。5-氟胞嘧啶与咪唑衍生物之间也有协同作用的报道。作者在此通过液体培养基(酵母氮源和脑心浸液)中的半自动方法,测试了5-氟胞嘧啶与咪唑衍生物(咪康唑、酮康唑、氟康唑、伊曲康唑)对57株耐5-氟胞嘧啶菌株的协同作用。5-氟胞嘧啶与抗真菌咪唑类药物之间的协同作用因所测试的药物不同而有很大差异。酮康唑的协同作用更常见。伊曲康唑和氟康唑在体外几乎没有协同作用。